Wordt geladen...
Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat psychosis, with all of the currently available antipsychotics acting through the antagonism of dopamine D2 receptors. Although antipsychotics reduce psychotic symptoms in many patients, they induce numero...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8123139/ https://ncbi.nlm.nih.gov/pubmed/33922888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22094467 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|